TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
planned
Official procurement procedure

Cell selection system for the preparation of purified stem cells

Diagnostic devices
Diagnostic supplies
Diagnostic systems
+1 more
Published value
£6,000,000
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Blood and Transplant: "Cell selection system for the preparation of purified stem cells". Published status: planned. Published value: £6,000,000. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS Blood and TransplantScope & CategoriesNot publishedSubmission Window
planned
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)£6,000,000
Bidder Intelligence · Authority Profile: NHS Blood and Transplant
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS Blood and Transplant. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
2Bids / Report
46.2% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 15 active published awards; 13 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS Blood and Transplant
Procedure methodNot published
Procurement categoryNot published
Statusplanned
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published5 Jul 2024, 16:47 BST
Last source update5 Jul 2024, 16:47 BST
Recurring procurementNot published
ClassificationDiagnostic devices, Diagnostic supplies, Diagnostic systems, Laboratory reagents
Delivery area
OCIDocds-h6vhtk-047b4c
What is being bought
This Prior Information Notice (PIN) is separate to any tender opportunity.<br/>The Cellular & Molecular Therapies (CMT) laboratories within NHS Blood and Transplant ( NHSBT) provide a range of services to support haemopoietic stem cell transplantation including collection, processing, and cryopreservation of stem cells. An important part of the services offered by CMT is the purification of stem cells and depletion of other cells, such as CD3+, TCRαβ, CD19+ cells, that may cause complications in the transplant procedures.<br/>The purpose of this notice is to:<br/>• Alert potential suppliers that NHSBT intends to award a contract for the supply of consumables and maintenance of existing equipment and in addition potential purchase of new equipment & maintenance in the future if demand increases.<br/>• Develop NHSBTs understanding of the capabilities, dependencies and competitiveness of the marketplace and the ability of industry to provide the required level of support.<br/>Please express your interest by the 29th of July and direct any questions to tennille.madigan@nhsbt.nhs.uk
What changed
From the official release history
  1. Published value updated to £6,000,000
    5 Jul 2024, 16:47 BST
  2. Status changed to planned
    5 Jul 2024, 16:47 BST
  3. Official notice release published
    5 Jul 2024, 16:47 BST
  4. Buyer information updated
    5 Jul 2024, 16:47 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    planned
    Published valueNot published
    This Prior Information Notice (PIN) is separate to any tender opportunity.<br/>The Cellular & Molecular Therapies (CMT) laboratories within NHS Blood and Transplant ( NHSBT) provide a range of services to support haemopoietic stem cell transplantation including collection, processing, and cryopreservation of stem cells. An important part of the services offered by CMT is the purification of stem cells and depletion of other cells, such as CD3+, TCRαβ, CD19+ cells, that may cause complications in the transplant procedures.<br/>The purpose of this notice is to:<br/>• Alert potential suppliers that NHSBT intends to award a contract for the supply of consumables and maintenance of existing equipment and in addition potential purchase of new equipment & maintenance in the future if demand increases.<br/>• Develop NHSBTs understanding of the capabilities, dependencies and competitiveness of the marketplace and the ability of industry to provide the required level of support.<br/>Please express your interest by the 29th of July and direct any questions to tennille.madigan@nhsbt.nhs.uk
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    5 Jul 2024, 16:47 BST
Commercial outcome and competition
AwardsNo award published
ContractsNo contract published
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

NHS Blood and Transplant

Contracting authority GB-FTS-13217
View buyer profile
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published